You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carbidopa-Levodopa Extended-Release Tablets

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease Trial in Ahmedabad (WD-1603 Carbidopa-Levodopa Extended-Release Tablets)

Recruiting
  • Parkinson Disease
  • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
  • Ahmedabad, Gujarat, India
    Lambda Therapeutic Research Ltd.
Nov 10, 2021

Parkinson Disease Trial in Shanghai (WD-1603 Carbidopa-Levodopa Extended-Release Tablets, Placebo)

Recruiting
  • Parkinson Disease
  • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
  • Placebo
  • Shanghai, Shanghai, China
    Shanghai Huashan Hospital
Oct 28, 2021

Parkinson Disease Trial in Ahmedabad (WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS)

Unknown status
  • Parkinson Disease
  • WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS
  • Ahmedabad, India
    Lambda Therapeutic Research Ltd.
Oct 11, 2020

Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets

Not yet recruiting
  • Healthy
  • Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
  • Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
  • (no location specified)
Jul 26, 2023

Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,

Not yet recruiting
  • Idiopathic Parkinson Disease
  • levodopa/carbidopa oral formulation A
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota
Jul 20, 2022

Parkinson Disease Trial in Ahmedabad (WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS)

Recruiting
  • Parkinson Disease
  • WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS
  • Ahmedabad, India
    Lambda Therapeutic Research Ltd.
Sep 9, 2020

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)

Not yet recruiting
  • Epilepsy
  • Lacosamide Tablets
  • Lacosamide extended release tablets
  • Wuhan, Hubei, China
    Union Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023

Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Somatic Symptom
  • toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
May 6, 2023

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Major Depressive Disorder
  • Toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 7, 2023

Bioequivalence Trial in Chennai (Levodopa 250mg and Carbidopa 25mg Test Drug tablet, Levodopa 250mg and Carbidopa 25mg Referent

Completed
  • Bioequivalence
  • Levodopa 250mg and Carbidopa 25mg Test Drug tablet
  • Levodopa 250mg and Carbidopa 25mg Referent Product tablet
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Mar 7, 2022

Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending

Not yet recruiting
  • Bladder Cancer
  • APL-1202 and APL-1501 (Single ascending dose)
  • APL-1202 and APL-1501 (Multiple Ascending dose)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Sep 11, 2023

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy With Cataplexy
  • (no location specified)
Jun 21, 2023

Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)

Recruiting
  • Hemophilia B
  • Sodium valproate extended-release tablets
  • Beijing, China
    PLA General Hospital
Jun 17, 2023

Prader-Willi Syndrome Trial (DCCR)

Not yet recruiting
  • Prader-Willi Syndrome
  • (no location specified)
Jan 26, 2023

Ulcerative Colitis Trial (Low Dose Budesonide, High Dose Budesonide, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Low Dose Budesonide
  • +2 more
  • (no location specified)
Sep 7, 2022

Multiple Sclerosis, Spasticity, Muscle Trial in Fresno (Arbaclofen)

Completed
Has Results
  • Multiple Sclerosis
  • Spasticity, Muscle
  • Fresno, California
    Neuro Pain Medical Center
Jul 14, 2022

Epilepsy Trial in Dhulikhel (Sodium valproate and valproic acid extended release tablet)

Not yet recruiting
  • Epilepsy
  • Sodium valproate and valproic acid extended release tablet
  • Dhulikhel, Bagmati, Nepal
  • +1 more
Dec 6, 2022

Parkinson Disease Trial (Stalevo, Carbidopa and Levodopa Controlled Release Tablets)

Not yet recruiting
  • Parkinson Disease
  • Stalevo
  • Carbidopa and Levodopa Controlled Release Tablets
  • (no location specified)
Jul 4, 2021

Advanced Parkinson's Disease Trial (Levodopa-Carbidopa Intestinal Gel, Percutaneous Endoscopic Gastrostomy with Jejunal

Completed
Has Results
  • Advanced Parkinson's Disease
  • Levodopa-Carbidopa Intestinal Gel
  • +2 more
  • (no location specified)
Jul 14, 2021